TD Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-223,218
Closed -$5.43M 1486
2023
Q1
$5.43M Buy
223,218
+60,800
+37% +$1.33M 0.01% 731
2022
Q4
$3.48M Buy
162,418
+21,992
+16% +$469K ﹤0.01% 836
2022
Q3
$2.43M Sell
140,426
-11,429
-8% -$150K ﹤0.01% 947
2022
Q2
$1.46M Sell
151,855
-53,725
-26% -$674K ﹤0.01% 1096
2022
Q1
$3.46M Sell
205,580
-12,100
-6% -$179K ﹤0.01% 921
2021
Q4
$3.64M Hold
217,680
﹤0.01% 959
2021
Q3
$3.54M Buy
217,680
+21,798
+11% +$237K ﹤0.01% 917
2021
Q2
$1.69M Buy
195,882
+40,250
+26% +$260K ﹤0.01% 1141
2021
Q1
$962K Buy
155,632
+36,455
+31% +$221K ﹤0.01% 1268
2020
Q4
$824K Hold
119,177
﹤0.01% 1223
2020
Q3
$672K Sell
119,177
-6,313
-5% -$30.1K ﹤0.01% 1175
2020
Q2
$640K Buy
+125,490
New +$523K ﹤0.01% 1166
2017
Q1
Sell
-12,418
Closed -$60K 1430
2016
Q4
$60K Sell
12,418
-34,182
-73% -$1.01M ﹤0.01% 1362
2016
Q3
$2.15M Buy
46,600
+3,100
+7% +$175K ﹤0.01% 862
2016
Q2
$2.22M Sell
43,500
-400
-0.9% -$19.9K ﹤0.01% 841
2016
Q1
$1.86M Buy
43,900
+3,400
+8% +$173K ﹤0.01% 855
2015
Q4
$3.18M Sell
40,500
-800
-2% -$46.3K 0.01% 758
2015
Q3
$1.67M Buy
41,300
+1,000
+2% +$53K ﹤0.01% 839
2015
Q2
$2.1M Buy
40,300
+12,900
+47% +$642K ﹤0.01% 849
2015
Q1
$1.27M Buy
27,400
+2,600
+10% +$135K ﹤0.01% 902
2014
Q4
$1.11M Buy
24,800
+700
+3% +$29.4K ﹤0.01% 914
2014
Q3
$938K Buy
24,100
+5,000
+26% +$196K ﹤0.01% 913
2014
Q2
$808K Sell
19,100
-1,000
-5% -$36.7K ﹤0.01% 935
2014
Q1
$718K Buy
20,100
+5,000
+33% +$169K ﹤0.01% 951
2013
Q4
$488K Buy
+15,100
New +$448K ﹤0.01% 1025

Other funds holding ISEE

TD Asset Management's ISEE Position: Q2 2023 in Review

TD Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 223,218 shares — an estimated $5.43M sold.

TD Asset Management first reported a position in ISEE in Q4 2013 and held it in 25 quarters. The position peaked at $5.43M in Q1 2023. 256 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • TD Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • TD Asset Management sold 223,218 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $5.43M.
  • TD Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 25 quarters.
  • TD Asset Management's IVERIC bio, Inc. Common Stock position peaked at $5.43M in Q1 2023.
  • 256 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on TD Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.